Tokyo-based Startup Secures $42.9M Series B To Diagnose Gastric Cancer Earlier With AI

Tokyo-based AI Medical Service Inc., which is developing endoscopic software powered by artificial intelligence, announced today that it has raised $42.9 million in a Series B round. Japan's Globis Capital Partners, World Innovation Lab (WiL) out of Palo Alto and Sony Innovation Fund by IGV (Innovation Growth Ventures), and others participated in the financing. Combined with the company's last raise of $9 million in August 2018, AI Medical Service has now brought in about $57 million in venture funding since its inception in September 2017. In its own words, the company "develops AI technology that brings together the wisdom of Japanese endoscopic specialists and supports endoscopic examinations of gastrointestinal organs, such as the esophagus, stomach, small intestine and large intestine." Its goal is to more quickly and efficiently diagnose gastric cancer.